What Is the Treatment for Recurrent or Metastatic Lip and Oral Cavity Cancer?
When oral cavity cancer recurs locally or presents with metastatic disease, the path forward depends heavily on what treatment was given at initial diagnosis. The choice of salvage approach is not uniform — it is shaped by the site of the recurrent lesion, its extent, and whether surgery or radiation therapy was the primary modality used first.
Clinical Scenario
This protocol addresses patients with recurrent or metastatic disease involving the lip and oral cavity — including the anterior tongue, buccal mucosa, floor of the mouth, retromolar trigone, upper gingiva, and hard palate. The location and size of the recurrent lesion, along with the patient's prior treatment history, are the key variables that guide management.
Treatment Approach — Partial Overview
Salvage therapy is tailored to prior treatment: when radiation therapy was the initial modality, surgery tends to be the preferred option at recurrence. When surgery was used initially, the range of options broadens — though the specific selection and sequencing requires evaluation of multiple clinical factors. The complete decision algorithm is available in the full protocol.
References
- For lesions of the lip, anterior tongue, buccal mucosa, floor of the mouth, retromolar trigone, upper gingiva, and hard palate, treatment is dictated by the location and size of the recurrent lesion as well as prior treatment.
- Surgery is the preferred treatment if radiation therapy was used initially.
- Surgery, radiation therapy, or a combination of these treatments may be considered if surgery was used to treat the lesion initially.
View source ↗